Kajian Formulasi Sediaan Floating Drug Delivery System (FDDS) Pada Pengobatan Infeksi Helicobacter pylori
Abstract
Abstract. Floating drug delivery system (FDDS) is a drug delivery system that can increase the residence time in the stomach. This delivery system was developed to increase the effectiveness of treatment of H. pylori infection, by extending the contact time with the mucosa (target), through the mechanism of floating in gastric fluid. This study aims to assess the formulation of FDDS preparations for the treatment of H. pylori infection. In this study, a systematic literature review was conducted from reputable articles based on inclusion and exclusion criteria. From this study, several conclusions were obtained that FDDS preparations have been developed on the active substances amoxycillin, clarithromycin, ciprofloxacin, metronidazole, and levofloxacin. Formulations using effervescent and non-effervescent systems meet the requirements of a good FDDS preparation, which has a floating lag time of <60-600 seconds and a floating time of >12 hours. The most widely used polymers were sodium alginate and HPMC.
Abstrak. Floating drug delivery system (FDDS) merupakan sistem penghantaran obat yang dapat meningkatkan waktu tinggal di lambung. Sistem penghantaran ini dikembangkan untuk meningkatkan efektivitas pengobatan infeksi H. pylori, dengan cara memperpanjang waktu kontak dengan mukosa (target kerja), melalui mekanisme mengapung di cairan lambung. Penelitian ini bertujuan untuk melakukan pengkajian mengenai formulasi pada sediaan FDDS untuk pengobatan infeksi H. pylori. Dalam penelitian ini dilakukan systematic literatur review yang bersumber dari artikel bereputasi berdasarkan kriteria inklusi dan eksklusi. Dari penelitian ini didapatkan beberapa kesimpulan bahwa sediaan FDDS telah dikembangkan pada zat aktif amoxycillin, claritromycin, ciprofloxacin, metronidazol, dan levofloxacin. Formulasi dengan menggunakan sistem effervescent dan non-effervescent memenuhi persyaratan sediaan FDDS yang baik, yaitu memiliki floating lag time <60-600 detik dan floating time >12 jam. Polimer yang paling banyak digunakan adalah sodium alginat dan HPMC.
References
[2] Simadibrata. Konsensus Nas. Penatalaksanaan Dispepsia dan Infeksi Helicobacter pylori, p. xvi+16 halaman, 2014.
[3] S. Diaconu, A. Predescu, A. Moldoveanu, C. S. Pop, and C. Fierbințeanu-Braticevici, “Helicobacter pylori infection: old and new.,” J. Med. Life, vol. 10, no. 2, pp. 112–117, 2017.
[4] L. Luciana, F. S. Maelaningsih, and D. P. Sari, “Penggunaan Proton Pump Inhibitor Pada Pasien Rawat Jalan Di Rsia Dhia Ciputat Tangerang Selatan,” Edu Masda J., vol. 6, no. 1, p. 36, 2022, doi: 10.52118/edumasda.v6i1.151.
[5] A. Ozturk, “Periodontal Treatment Is Associated With Improvement in Gastric Helicobacter pylori Eradication: An Updated Meta-analysis of Clinical Trials,” Int. Dent. J., vol. 71, no. 3, pp. 188–196, 2021, doi: 10.1111/idj.12616.
[6] A. Talebi Bezmin Abadi, “Helicobacter pylori treatment: New perspectives using current experience,” J. Glob. Antimicrob. Resist., vol. 8, pp. 123–130, 2017, doi: 10.1016/j.jgar.2016.11.008.
[7] C. B. Adebisi A, “Gastroretentive microparticles for drug delivery applications. J Microencapsul,” J Microencapsul, vol. 28, pp. 689–708, 2011, doi: 10.3109/02652048.2011.590613.
[8] D. J. Ankit Namdev, “Floating Drug Delivery Systems: An Emerging Trend for the Treatment of Peptic Ulcer,” Curr Drug Deliv, vol. 16, no. 10, pp. 874–886, 2019, doi: 10.2174/1567201816666191018163519.
[9] R. A. H. Ishak, “Buoyancy-generating agents for stomach-specific drug delivery: An overview with special emphasis on floating behavior,” J. Pharm. Pharm. Sci., vol. 18, no. 1, pp. 77–100, 2015, doi: 10.18433/j3602k.
[10] N. Dudhipala and A. Narala, “Amoxycillin Trihydrate Floating-Bioadhesive Drug Delivery System for Eradication of Helicobacter pylori: Preparation, In Vitro and Ex Vivo Evaluation,” J. Bioequiv. Availab., vol. 08, no. 03, 2013, doi: 10.4172/jbb.1000280.
[11] V. S. Meka, V. A. H. W. Liang, S. R. Dharmalingham, R. Sheshala, and A. Gorajana, “Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate,” Acta Pharm., vol. 64, no. 4, pp. 485–494, 2014, doi: 10.2478/acph-2014-0038.
[12] V. Srikanth Meka, C. Ee Li, and R. Sheshala, “Design and statistical optimization of an effervescent floating drug delivery system of theophylline using response surface methodology,” Acta Pharm., vol. 66, no. 1, pp. 35–51, 2016, doi: 10.1515/acph-2016-0002.
[13] S. A. El-Zahaby, A. A. Kassem, and A. H. El-Kamel, “Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori,” Saudi Pharm. J., vol. 22, no. 6, pp. 570–579, 2014, doi: 10.1016/j.jsps.2014.02.009.
[14] H. Patil, R. V. Tiwari, and M. A. Repka, “Recent advancements in mucoadhesive floating drug delivery systems: A mini-review,” J. Drug Deliv. Sci. Technol., vol. 31, pp. 65–71, 2016, doi: 10.1016/j.jddst.2015.12.002.
[15] T. Uǧurlu, U. Karaçi̧cek, and E. Rayaman, “Optimization and evaluation of clarithromycin floating tablets using experimental mixture design,” Acta Pol. Pharm. - Drug Res., vol. 71, no. 2, pp. 311–321, 2014.
[16] M. M. Louis, A. A. Badawy, D. I. Nessem, and N. S. Abd Elmalak, “Drotaverine hydrochloride gastroretentive floating mini-tablets: Formulation, in-vitro and in-vivo evaluation,” J. Drug Deliv. Sci. Technol., vol. 57, no. January, p. 101733, 2020, doi: 10.1016/j.jddst.2020.101733.
[17] S. Treesinchai, S. Puttipipatkhachorn, T. Pitaksuteepong, and S. Sungthongjeen, “Development of curcumin floating beads with low density materials and solubilizers,” J. Drug Deliv. Sci. Technol., vol. 51, no. January, pp. 542–551, 2019, doi: 10.1016/j.jddst.2019.03.002.
[18] N. A. H. Abou Youssef, A. A. Kassem, M. A. E. El-Massik, and N. A. Boraie, “Development of gastroretentive metronidazole floating raft system for targeting Helicobacter pylori,” Int. J. Pharm., vol. 486, no. 1–2, pp. 297–305, 2015, doi: 10.1016/j.ijpharm.2015.04.004.
[19] N. D. Reddy and A. B. Reddy, “Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers,” Drug Res. (Stuttg)., vol. 67, no. 7, pp. 412–418, 2017, doi: 10.1055/s-0043-102952.
[20] N. A. Thombre and P. S. Gide, “Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication,” Drug Deliv., vol. 23, no. 2, pp. 405–419, 2016, doi: 10.3109/10717544.2014.916766.
[21] A. O. Adebisi, P. R. Laity, and B. R. Conway, “Formulation and evaluation of floating mucoadhesive alginate beads for targeting Helicobacter pylori,” J. Pharm. Pharmacol., vol. 67, no. 4, pp. 511–524, 2015, doi: 10.1111/jphp.12345.
[22] S. K. Dey et al., “Floating mucoadhesive alginate beads of amoxicillin trihydrate: A facile approach for H. pylori eradication,” Int. J. Biol. Macromol., vol. 89, pp. 622–631, 2016, doi: 10.1016/j.ijbiomac.2016.05.027.
[23] A. O. Adebisi and B. R. Conway, “Preparation and characterisation of gastroretentive alginate beads for targeting H. pylori,” J. Microencapsul., vol. 31, no. 1, pp. 58–67, 2014, doi: 10.3109/02652048.2013.805840.
[24] F. Naseem, S. U. Shah, S. A. Rashid, A. Farid, M. Almehmadi, and S. Alghamdi, “Metronidazole Based Floating Bioadhesive Drug Delivery System for Potential Eradication of H. pylori: Preparation and In Vitro Characterization,” Polymers (Basel)., vol. 14, no. 3, pp. 1–24, 2022, doi: 10.3390/polym14030519.
[25] S. P. Sari, A. N. Bestari, and T. N. S. Sulaiman, “Optimasi Formula Tablet Floating Famotidin Menggunakan Kombinasi Matriks Gum Xanthan dan Hidroksi Propil Metil Selulosa K100M,” Maj. Farm., vol. 15, no. 2, p. 86, 2019, doi: 10.22146/farmaseutik.v15i2.46878.
[26] E. Setyorini, E. D. Irawan, L. Oktora, and R. Kumala, “Optimasi Hydroxypropyl Methylcellulose dan Xanthan Gum pada Tablet Floating-Mucoadhesive Gliclazide Metode Desain Faktorial ( Optimization of Hydroxypropyl Methylcellulose and Xanthan Gum on Floating-Mucoadhesive Gliclazide Tablet using Factorial Design ),” e-Jurnal Pustaka Kesehat., vol. 4, no. 2, pp. 249–254, 2016.
